162 related articles for article (PubMed ID: 34957697)
21. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
Dupont PJ; Warrens AN
Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
[TBL] [Abstract][Full Text] [Related]
22. ANO9 regulates PD-L2 expression and binding ability to PD-1 in gastric cancer.
Katsurahara K; Shiozaki A; Kosuga T; Shimizu H; Kudou M; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Otsuji E
Cancer Sci; 2021 Mar; 112(3):1026-1037. PubMed ID: 33404124
[TBL] [Abstract][Full Text] [Related]
23. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
[TBL] [Abstract][Full Text] [Related]
24. Long-term use of indomethacin leads to poor prognoses through promoting the expression of PD-1 and PD-L2 via TRIF/NF-κB pathway and JAK/STAT3 pathway to inhibit TNF-α and IFN-γ in hepatocellular carcinoma.
Xu P; Sun Z; Wang Y; Miao C
Exp Cell Res; 2015 Sep; 337(1):53-60. PubMed ID: 26162855
[TBL] [Abstract][Full Text] [Related]
25. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
26. A risk signature with inflammatory and immune cells infiltration predicts survival and efficiency of chemotherapy in gastric cancer.
Li S; Sun S; Sun H; Ma P; Zhang J; Cao Y; Liu C; Zhang X; Wang W; Li Z; Ma Y; Xue Y; Zhao Y
Int Immunopharmacol; 2021 Jul; 96():107589. PubMed ID: 34162126
[TBL] [Abstract][Full Text] [Related]
27. Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
Ubukata Y; Ogata K; Sohda M; Yokobori T; Shimoda Y; Handa T; Nakazawa N; Kimura A; Kogure N; Sano A; Sakai M; Ogawa H; Kuwano H; Shirabe K; Oyama T; Saeki H
Oncology; 2021; 99(1):15-22. PubMed ID: 33113541
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil expression of Fas ligand and perforin directs effector CD8 T cell infiltration into antigen-challenged skin.
Kish DD; Gorbachev AV; Parameswaran N; Gupta N; Fairchild RL
J Immunol; 2012 Sep; 189(5):2191-202. PubMed ID: 22815291
[TBL] [Abstract][Full Text] [Related]
29. Tristetraprolin Overexpression in Gastric Cancer Cells Suppresses PD-L1 Expression and Inhibits Tumor Progression by Enhancing Antitumor Immunity.
Guo J; Qu H; Shan T; Chen Y; Chen Y; Xia J
Mol Cells; 2018 Jul; 41(7):653-664. PubMed ID: 29936792
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.
Hiramatsu S; Tanaka H; Nishimura J; Sakimura C; Tamura T; Toyokawa T; Muguruma K; Yashiro M; Hirakawa K; Ohira M
BMC Immunol; 2018 Apr; 19(1):13. PubMed ID: 29661142
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract][Full Text] [Related]
32. Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma.
Peng ZP; Jiang ZZ; Guo HF; Zhou MM; Huang YF; Ning WR; Huang JH; Zheng L; Wu Y
J Hepatol; 2020 Oct; 73(4):906-917. PubMed ID: 32407813
[TBL] [Abstract][Full Text] [Related]
33. Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition.
Zhang W; Gu J; Chen J; Zhang P; Ji R; Qian H; Xu W; Zhang X
Oncol Rep; 2017 Nov; 38(5):2959-2966. PubMed ID: 28901479
[TBL] [Abstract][Full Text] [Related]
34. PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms.
Nakano H; Saito M; Nakajima S; Saito K; Nakayama Y; Kase K; Yamada L; Kanke Y; Hanayama H; Onozawa H; Okayama H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Goto A; Kono K
Sci Rep; 2021 Jan; 11(1):1982. PubMed ID: 33479394
[TBL] [Abstract][Full Text] [Related]
35. CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer.
Zhuang Y; Peng LS; Zhao YL; Shi Y; Mao XH; Chen W; Pang KC; Liu XF; Liu T; Zhang JY; Zeng H; Liu KY; Guo G; Tong WD; Shi Y; Tang B; Li N; Yu S; Luo P; Zhang WJ; Lu DS; Yu PW; Zou QM
Gastroenterology; 2012 Oct; 143(4):951-62.e8. PubMed ID: 22710190
[TBL] [Abstract][Full Text] [Related]
36. miR-155-5p inhibition promotes the transition of bone marrow mesenchymal stem cells to gastric cancer tissue derived MSC-like cells via NF-κB p65 activation.
Zhu M; Wang M; Yang F; Tian Y; Cai J; Yang H; Fu H; Mao F; Zhu W; Qian H; Xu W
Oncotarget; 2016 Mar; 7(13):16567-80. PubMed ID: 26934326
[TBL] [Abstract][Full Text] [Related]
37. Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy.
Huang KC; Chiang SF; Chen TW; Chen WT; Yang PC; Ke TW; Chao KSC
Sci Rep; 2020 Dec; 10(1):22330. PubMed ID: 33339860
[TBL] [Abstract][Full Text] [Related]
38. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression.
Xiao X; Lao XM; Chen MM; Liu RX; Wei Y; Ouyang FZ; Chen DP; Zhao XY; Zhao Q; Li XF; Liu CL; Zheng L; Kuang DM
Cancer Discov; 2016 May; 6(5):546-59. PubMed ID: 26928313
[TBL] [Abstract][Full Text] [Related]
39. PD-1 and PD-L1 co-expression predicts favorable prognosis in gastric cancer.
Wu Y; Cao D; Qu L; Cao X; Jia Z; Zhao T; Wang Q; Jiang J
Oncotarget; 2017 Sep; 8(38):64066-64082. PubMed ID: 28969052
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic T-lymphocyte-associated protein 4 in gastric cancer: Prognosis and association with PD-L1 expression.
Pereira MA; de Castria TB; Ramos MFKP; Dias AR; Cardili L; de Moraes RDR; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
J Surg Oncol; 2021 Dec; 124(7):1040-1050. PubMed ID: 34255356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
